Device Firms Puzzle Through Intricacies Of Sunshine Act Compliance
This article was originally published in The Gray Sheet
Device makers are thinking through the details of how they will report their provision of demo units, evaluation products and loaner equipment to doctors and hospitals.
You may also be interested in...
Two-and-a-half months late and with only a draft version of the regulations released, CMS is giving device and drug companies, and GPOs, more time to prepare for impending requirements to report physician payments and investment interests to the government for public posting.
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.
The Stark Law ban on self-referrals wouldn’t apply to some physician owners of advanced imaging facilities under a CMS final rule.